Overview
- The ITIA said Bagnis’s in-competition sample from August 18 at US Open qualifying returned an A-sample positive for hydrochlorothiazide, a prohibited diuretic and masking agent.
- Officials issued a notice of charge on October 2 for use of a banned substance without a valid therapeutic exemption.
- Bagnis began a voluntary provisional suspension on October 18, with time served to be credited toward any potential sanction.
- During the suspension, he is barred from playing, training, or attending events sanctioned by ITIA members including ATP, WTA, ITF and national associations.
- Bagnis stated he was surprised by the result, asserted his innocence, and said his team is exploring possible cross-contamination as the case proceeds.